On the way to deprescribing levothyroxine in subclinical hypothyroidism in general practice – the patients’ perspective of enablers and barriers

Background Recent studies indicate that the synthetic thyroid hormone levothyroxine (LTX) in many cases has no beneficial effects on patients with subclinical hypothyroidism. Still, prescriptions are increasing worldwide. If there is no clear indication for treatment, patients treated with LTX shoul...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: M. Rennert, A. K. Geier, L. Christ, S. Hager, S. Scheibe, A. Rettich, J. Schübel, T. Deutsch, M. Bleckwenn, K. Voigt
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis Group 2025-12-01
Серии:European Journal of General Practice
Предметы:
Deprescribing
qualitative research
patient involvement
levothyroxine
subclinical hypothyroidism
Online-ссылка:https://www.tandfonline.com/doi/10.1080/13814788.2025.2571605
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы